tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

JNJ Stock Latest News

Lava Therapeutics Boils Up Thanks to New Deal
Market NewsLava Therapeutics Boils Up Thanks to New Deal
4d ago
JNJ
LVTX
JNJ Whistleblower Case Dismissed Over Confidentiality Breach
Market NewsJNJ Whistleblower Case Dismissed Over Confidentiality Breach
4d ago
JNJ
HDV: This Dividend ETF Proves That High Yield Isn’t Always Best
Stock Analysis & IdeasHDV: This Dividend ETF Proves That High Yield Isn’t Always Best
15d ago
KO
BLK
Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears
Stock Analysis & IdeasBillionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears
20d ago
ABT
JNJ
Johnson and Johnson IPO Today – Consumer Healthcare Unit Starts Trading at $22
Market NewsJohnson and Johnson IPO Today – Consumer Healthcare Unit Starts Trading at $22
1M ago
JNJ
Johnson & Johnson’s Kenvue to price at $22 per share, Bloomberg says
The FlyJohnson & Johnson’s Kenvue to price at $22 per share, Bloomberg says
1M ago
JNJ
J&J’s Janssen reports 72.7% complete response rate in bladder cancer study
The FlyJ&J’s Janssen reports 72.7% complete response rate in bladder cancer study
1M ago
JNJ
J&J’s Kenvue spinoff a rare IPO winner in moribund market, Barron’s says
The FlyJ&J’s Kenvue spinoff a rare IPO winner in moribund market, Barron’s says
1M ago
JNJ
Johnson & Johnson’s Kenvue targeted by talcum powder cancer claims, FT reports
The FlyJohnson & Johnson’s Kenvue targeted by talcum powder cancer claims, FT reports
1M ago
JNJ
Alkermes arbitration award better than expected, says Mizuho
The FlyAlkermes arbitration award better than expected, says Mizuho
1M ago
JNJ
ALKS
Legend Biotech price target raised to $90 from $79 at BMO Capital
The FlyLegend Biotech price target raised to $90 from $79 at BMO Capital
1M ago
JNJ
LEGN
Alkermes receives second interim award in Janssen arbitration
The FlyAlkermes receives second interim award in Janssen arbitration
1M ago
JNJ
ALKS
Johnson & Johnson management to meet virtually with Oppenheimer
The FlyJohnson & Johnson management to meet virtually with Oppenheimer
1M ago
JNJ
Arcellx price target raised to $58 from $45 at Guggenheim
The FlyArcellx price target raised to $58 from $45 at Guggenheim
1M ago
JNJ
ACLX
Johnson & Johnson Eyes 40B Valuation for its Consumer Health Unit
Market NewsJohnson & Johnson Eyes 40B Valuation for its Consumer Health Unit
1M ago
JNJ
J&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says
The FlyJ&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says
1M ago
JNJ
Legend Biotech Blasts Up on Cancer Data
Market NewsLegend Biotech Blasts Up on Cancer Data
2M ago
JNJ
LEGN
J&J granted marketing authorization for Akeega in Europe
The FlyJ&J granted marketing authorization for Akeega in Europe
2M ago
JNJ
MeiraGTx announces upcoming presentations at ARVO 2023 meeting
The FlyMeiraGTx announces upcoming presentations at ARVO 2023 meeting
2M ago
JNJ
MGTX
J&J wins temporary halt of baby powder lawsuits, Bloomberg says
The FlyJ&J wins temporary halt of baby powder lawsuits, Bloomberg says
2M ago
JNJ
Legend Biotech price target raised to $85 from $75 at BTIG
The FlyLegend Biotech price target raised to $85 from $75 at BTIG
2M ago
JNJ
NVS
Legend Biotech CARTITUDE-4 data ‘highly impressive,’ says Guggenheim
The FlyLegend Biotech CARTITUDE-4 data ‘highly impressive,’ says Guggenheim
2M ago
BMY
JNJ